These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. An unusual case of cardiac amyloidosis. Garibaldi B; Zaas D J Gen Intern Med; 2007 Jul; 22(7):1047-52. PubMed ID: 17447098 [TBL] [Abstract][Full Text] [Related]
4. Cardiac amyloidosis: the heart of the matter. Perfetto F; Cappelli F; Bergesio F; Ciuti G; Porciani MC; Padeletti L; Moggi Pignone A Intern Emerg Med; 2013 Apr; 8(3):191-203. PubMed ID: 21739229 [TBL] [Abstract][Full Text] [Related]
5. AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy. Falk RH; Alexander KM; Liao R; Dorbala S J Am Coll Cardiol; 2016 Sep; 68(12):1323-41. PubMed ID: 27634125 [TBL] [Abstract][Full Text] [Related]
6. Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management. Hassan W; Al-Sergani H; Mourad W; Tabbaa R Tex Heart Inst J; 2005; 32(2):178-84. PubMed ID: 16107109 [TBL] [Abstract][Full Text] [Related]
8. Transthyretin cardiac amyloidosis: an update on diagnosis and treatment. Yamamoto H; Yokochi T ESC Heart Fail; 2019 Dec; 6(6):1128-1139. PubMed ID: 31553132 [TBL] [Abstract][Full Text] [Related]
9. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know]. Arbustini E; Gavazzi A; Merlini G Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807 [TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition. Biolo A; Ramamurthy S; Connors LH; O'Hara CJ; Meier-Ewert HK; Soo Hoo PT; Sawyer DB; Seldin DC; Sam F Circ Heart Fail; 2008 Nov; 1(4):249-57. PubMed ID: 19808299 [TBL] [Abstract][Full Text] [Related]
11. Amyloid cardiomyopathy. Karafiatova L; Pika T Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Jun; 161(2):117-127. PubMed ID: 28145535 [TBL] [Abstract][Full Text] [Related]
12. Cardiac amyloidosis: the importance of a multidisciplinary approach. Gómez-Bueno M; Segovia J; García-Pavía P; Barceló JM; Krsnik I; Sánchez-Turrión V; Salas C; Alonso-Pulpón L Rev Esp Cardiol; 2009 Jun; 62(6):698-702. PubMed ID: 19480768 [TBL] [Abstract][Full Text] [Related]
13. Noninvasive Diagnostic Modalities in an Isolated Case of Cardiac Amyloidosis. Lewars J; Wazir H; Gordon B; Faluyi U; Girgis Y Cureus; 2021 Apr; 13(4):e14608. PubMed ID: 34040908 [TBL] [Abstract][Full Text] [Related]
17. Light chain cardiac amyloidosis - a rare cause of heart failure in a young adult. Domingues K; Saraiva M; Marta L; Monteiro I; Leal M Rev Assoc Med Bras (1992); 2018 Sep; 64(9):787-790. PubMed ID: 30672998 [TBL] [Abstract][Full Text] [Related]
18. Cardiac amyloidosis: a practical approach to diagnosis and management. Kapoor P; Thenappan T; Singh E; Kumar S; Greipp PR Am J Med; 2011 Nov; 124(11):1006-15. PubMed ID: 22017778 [TBL] [Abstract][Full Text] [Related]
19. A transgenic mouse model reproduces human hereditary systemic amyloidosis. Chabert M; Rousset X; Colombat M; Lacasa M; Kakanakou H; Bourderioux M; Brousset P; Burlet-Schiltz O; Liepnieks JJ; Kluve-Beckerman B; Lambert G; Châtelet FP; Benson MD; Kalopissis AD Kidney Int; 2019 Sep; 96(3):628-641. PubMed ID: 31200944 [TBL] [Abstract][Full Text] [Related]
20. New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis. Perlini S; Mussinelli R; Salinaro F Curr Heart Fail Rep; 2016 Dec; 13(6):267-272. PubMed ID: 27900617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]